Phendimetrazine Tartrate Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 35 mg, 105 mg
Reference Brands: Bontril (USA), Plegine (USA)
Category:
Weight Loss drugs
Phendimetrazine Tartrate is available in Capsules
and strengths such as 35 mg, 105 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Phendimetrazine Tartrate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Phendimetrazine Tartrate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Phendimetrazine tartrate is a sympathomimetic amine and an amphetamine congener, marketed under brand names such as Bontril, Plegine, and Prelu-2. It is used as a short-term appetite suppressant to assist in the management of obesity in adults as part of a comprehensive weight loss program that includes diet, exercise, and behavioral modification.
Structurally related to methamphetamine, phendimetrazine functions as a prodrug for phenmetrazine, its active metabolite. This unique metabolic pathway provides more favorable pharmacokinetics compared to phenmetrazine, producing a steady and prolonged release of the active compound in the body. This results in a lower peak blood concentration of phenmetrazine, reducing the potential for abuse while maintaining therapeutic efficacy. By stimulating the central nervous system, phendimetrazine suppresses appetite, helping patients control caloric intake and promote weight loss safely under medical supervision.
Phendimetrazine’s controlled-release profile and prodrug design make it an effective and safer alternative to direct phenmetrazine administration, allowing for regulated therapeutic action and improved compliance. It is intended strictly for short-term use and must be administered under professional guidance due to its stimulant properties and potential side effects.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing